Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank50
3Y CAGR-51.3%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-51.3%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.00-92.9%
20240.02+92.8%
20230.01-16.0%
20220.01-
20210.00-
20200.00-
20190.00-